era-edta  

isn

International Society of Nephrology

Under the hospices of ERA-EDTA& ISN/COMGAN
In cooperation with The Bulgaria Society of Nephrology
European Council for Accreditation in CME in Nephrology, Dialysis and Transplantation

 

From clinical nephrology and CKD related problems to prolonged kidney transplant survival

 

bari

Alexander Nevsky Chathedral, Sofia

October 11, 2008

Princess Hotel, Sofia

Sofia, Bulgaria

travelgrants

 

ERA-EDTA CME Activities

Chair-person: R. Coppo (Italy)

Secretary: A.L.M. De Francisco (Spain)

Members: J. Floege (Germany)

              R. Vanholder (Belgium)

              A. Wiecek (Poland)

              C. Zoccali (Italy)

              G.M. London, ERA-EDTA President (France)

CME Courses Coordinators:
Basic Science and Clinical Nephrology: R. Coppo (Italy) and P. Ronco (France).
Chronic Renal Failure, Hypertension and Clinical Epidemiology: C. Zoccali (Italy) and G. London (France).
Dialysis: R. Vanholder (Belgium), S. Davies (UK) and C. Wanner (Germany).
Transplantation: C. Ponticelli (Italy) and J. Grinyo (Spain).
Collaboration with ISN for courses in Eastern Europe: N. Lameire (Belgium), A. Covic (Romania).

 

 

 

 

 

 

 

 

 

 

 

 

ERA-EDTA Coordinators: Goce Spasovski and Norbert Lameire

Local Coordinators: P. Simeonov, B. Kiperova, Em. Paskalev

School Venue:
Sofia Princess Hotel
Phone: +359 2 933 8888
Fax: +359 2 933 8777

Web site: www.sofia-princess-hotel.com

REGISTRATION DEADLINE: June 1, 2008 (ON-SITE registration is also possible)

Official Agency:
CIC Ltd.
Phone: +359 2 892 08 08
Fax: +359 2 892 08 00
Web site: www.cic.bg
E-mail: cic@cic.bg

 

travelgrants

COURSE PROGRAMME

 

08.40
Welcome address
P. Simeonov, R. Coppo, N. Lameire, G. Spasovski
   
09.00
Focal segmental glomerulosclerosis - an update
J. Feehally(UK)
  
09.35
Pathogenesis and treatment of IgA nephropathy
R. Coppo (Italy)
   
   
10.10
Diabetic nephropathy pathophysiology
N. Lameire (Belgium)
   
   
10.45
Coffee break
   
   
11.15
HMG-CoA reductase inhibitors and the kidney
A. Covic (Romania)
   
   
11.50
Hyperhomocysteinaemia in CKD patients
E. Vazelov (Bulgaria)
   
12.25
Adequacy of dialysis - an update
   
V. Ikonomov (Bulgaria)
   
12.50
Lunch
   
14.30
Uremia and cardio-vascular risk
R. Vanholder (Belgium)
   
15.05
CKD-MBD and Outcomes. From Bench to Patient
J. Cannata (Spain)
   
15.40
Coffee break
   
16.15
Subclinical kidney rejections - the role of protocol biopsy
G. Spasovski (R. Macedonia)
   
16.50
Chronic allograft nephropathy
D. Goldsmith (UK)